Experimental drug turns cancer’s favorite fuel—sugar—against it
Peer-Reviewed Publication
Updates every hour. Last Updated: 29-Oct-2026 04:17 ET (29-Oct-2026 08:17 GMT/UTC)
Researchers have found a new way to trick cancer cells into consuming even more sugar than usual and, at the same time, block their backup fuel source—fat. By attacking both fuel sources at once, the experimental drug puts cancer cells under so much stress that many of them die. They demonstrated the drug’s effectiveness at treating an aggressive form of melanoma in mice.
A new portable blood testing device could allow patient health to be monitored at home through an app.
The meningococcal B (MenB) vaccine could provide protection against more than one disease, with new research linking it to a significant reduction in the risk of gonorrhoea in young people in parts of Australia.
Salidroside, the key active compound of Rhodiola plants with anti-hypoxia and anti-fatigue properties, is highly valued in medicine, health products, and cosmetics. A new study demonstrates an efficient dual-enzyme cascade system combining sucrose synthase and glycosyltransferase that achieves one-pot biosynthesis of salidroside with 90% conversion rate. Through solubility enhancement and thermostability engineering, the system produces 13.61 g/L salidroside within just 10 hours, establishing a practical platform for industrial-scale green production.
Nutrition strategies for concussion management are being implemented by dietitians to support Australia’s elite collision sport athletes, new Griffith University research has found.
A novel study shows that exposure to air pollution, especially fine particulate matter like dust, soot, and smoke (PM2.5), is associated with increased disease activity and flare risk in rheumatoid arthritis (RA). The findings from an article in the Annals of the Rheumatic Diseases (ARD), The EULAR Journal, published by Elsevier, underscore the importance for healthcare providers and policymakers to recognize its impact on the management of RA.
Not all women with pregnancy complications face the same risk of premature cardiovascular death. A new study from the University of Bergen found that risk varied markedly depending on the total number of pregnancies and whether complications occurred in a first or later pregnancy.